Status:
COMPLETED
Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Infectious Disease
Eligibility:
All Genders
18+ years
Brief Summary
The population of these monocentric and retrospective study includes patients hospitalized in one of the critical care services of Nîmes' community hospital. The objective is to determine the key fac...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient aged at least (≥) 18 years of age.
- Patient (or his representative for patients unable to give their consent) has given his free and informed consent and has signed the consent form.
- Patient affiliated to the health insurance scheme
- Patient hospitalized in one of the critical care services of Nimes' community hospital with at least one beta-lactam treatment
- Patient with at least one beta-lactam TDM during his stay
- Exclusion Criteria :
- Patient who did not consent the use of his personal data
- Patients under maintenance of justice, tutelage or legal guardianship
- Patient previously included in the study.
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT05352997
Start Date
January 1 2018
End Date
December 31 2022
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France, 30029